Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garret A FitzGerald

Showing results (1-10 of 301) with videos related to

Pageof 31
Sort By:
Science (New York, N.Y.)|June 13, 2015
BIOMEDICINE. Bringing PGE₂ in from the coldGarret A FitzGerald
Nature Reviews. Drug Discovery|December 12, 2003
COX-2 and beyond: Approaches to prostaglandin inhibition in human diseaseGarret A FitzGerald
The American Journal of Cardiology|March 23, 2002
Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerationsGarret A FitzGerald
Science Translational Medicine|June 17, 2016
Measure for Measure: Biomarker standards and transparencyGarret A FitzGerald
Science (New York, N.Y.)|November 22, 2014
Circadian Rhythms. Temporal targets of drug actionGarret A FitzGerald
Science Translational Medicine|May 20, 2011
NCATS purrs: emerging signs of form and functionGarret A FitzGerald
Nature Reviews. Drug Discovery|October 15, 2005
Opinion: anticipating change in drug development: the emerging era of translational medicine and therapeuticsGarret A Fitzgerald
Science (New York, N.Y.)|June 21, 2008
Drugs, industry, and academiaGarret A Fitzgerald
Arteriosclerosis, Thrombosis, and Vascular Biology|November 16, 2023
COX Postulates: Remember the FibroblastGarret A FitzGerald
The New England Journal of Medicine|October 8, 2004
Coxibs and cardiovascular diseaseGarret A Fitzgerald
Pageof 31

Showing results (1-10 of 301) with videos related to

Sort By:
Pageof 31
Science (New York, N.Y.)|June 13, 2015
BIOMEDICINE. Bringing PGE₂ in from the coldGarret A FitzGerald
Nature Reviews. Drug Discovery|December 12, 2003
COX-2 and beyond: Approaches to prostaglandin inhibition in human diseaseGarret A FitzGerald
The American Journal of Cardiology|March 23, 2002
Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerationsGarret A FitzGerald
Science Translational Medicine|June 17, 2016
Measure for Measure: Biomarker standards and transparencyGarret A FitzGerald
Science (New York, N.Y.)|November 22, 2014
Circadian Rhythms. Temporal targets of drug actionGarret A FitzGerald
Science Translational Medicine|May 20, 2011
NCATS purrs: emerging signs of form and functionGarret A FitzGerald
Nature Reviews. Drug Discovery|October 15, 2005
Opinion: anticipating change in drug development: the emerging era of translational medicine and therapeuticsGarret A Fitzgerald
Science (New York, N.Y.)|June 21, 2008
Drugs, industry, and academiaGarret A Fitzgerald
Arteriosclerosis, Thrombosis, and Vascular Biology|November 16, 2023
COX Postulates: Remember the FibroblastGarret A FitzGerald
The New England Journal of Medicine|October 8, 2004
Coxibs and cardiovascular diseaseGarret A Fitzgerald
Pageof 31